These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3553782)

  • 21. Long-acting injectable bromocriptine treatment for macroprolactinomas.
    Van Cutsem EJ; Lamberts SW
    Neth J Med; 1988 Apr; 32(3-4):112-7. PubMed ID: 3362265
    [No Abstract]   [Full Text] [Related]  

  • 22. Bromocriptine.
    Sherman BM; Chapler FK
    J Iowa Med Soc; 1980 May; 70(5):209-10, 212. PubMed ID: 7189202
    [No Abstract]   [Full Text] [Related]  

  • 23. Editorial: Bromocriptine.
    Lancet; 1975 May; 1(7915):1076. PubMed ID: 48738
    [No Abstract]   [Full Text] [Related]  

  • 24. Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature.
    Konopelska S; Quinkler M; Strasburger CJ; Ventz M
    J Clin Psychopharmacol; 2008 Feb; 28(1):120-2. PubMed ID: 18204364
    [No Abstract]   [Full Text] [Related]  

  • 25. Bromocriptine - an important advance.
    Drug Ther Bull; 1976 Apr; 14(9):33-4. PubMed ID: 1278002
    [No Abstract]   [Full Text] [Related]  

  • 26. Improvement of L-dopa induced dyskinesia and of on-off phenomenon by bromocriptine.
    Ludin HP
    Acta Neurol Belg; 1980; 80(1):5-9. PubMed ID: 7361542
    [No Abstract]   [Full Text] [Related]  

  • 27. Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995--bromocriptine combined treatment results.
    Cremonini N; Graziano E; Chiarini V; Sforza A; Zampa GA
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1166-9. PubMed ID: 1400888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bromocriptine and pituitary disorders.
    Kellett J; Friesen HG
    Ann Intern Med; 1979 Jun; 90(6):980-2. PubMed ID: 443696
    [No Abstract]   [Full Text] [Related]  

  • 29. Rapid progression of a growth hormone producing tumour during dopamine agonist treatment.
    Heidvall K; Hulting AL
    Br Med J (Clin Res Ed); 1987 Feb; 294(6571):546-7. PubMed ID: 3103768
    [No Abstract]   [Full Text] [Related]  

  • 30. The safety of bromocriptine in long-term use: a review of the literature.
    Weil C
    Curr Med Res Opin; 1986; 10(1):25-51. PubMed ID: 3516579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bromocriptine--a versatile remedy.
    Joffe BI; Distiller LA; Seftel HC
    S Afr Med J; 1977 Jun; 51(26):954-5. PubMed ID: 578015
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of acromegaly with dopamine agonists.
    Jaffe CA; Barkan AL
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):713-35. PubMed ID: 1355728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ergolines as potential prolactin and mammary tumor inhibitors.
    Cassady JM; Floss HG
    Lloydia; 1977; 40(1):90-106. PubMed ID: 327183
    [No Abstract]   [Full Text] [Related]  

  • 34. Resolution of migraine following bromocriptine treatment of a prolactinoma (pituitary microadenoma).
    Hartman N; Voron SC; Hershman JM
    Headache; 1995; 35(7):430-1. PubMed ID: 7672963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of acromegaly during treatment of hyperprolactinemia with bromocriptine: an unusual acidophil stem cell adenoma.
    Page MD; Bridges LR; Barth JH; McNichol AM; Belchetz PE
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4484-7. PubMed ID: 8954064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bromocryptin in obstetrics and gynecology].
    Alipov VI; Beskrovnaia NI
    Akush Ginekol (Mosk); 1980 Jul; (7):3-6. PubMed ID: 6998309
    [No Abstract]   [Full Text] [Related]  

  • 37. Bromocriptine treatment of prolactinoma restores growth hormone secretion and causes catch-up growth in a prepubertal child.
    Sakazume S; Obata K; Takahashi E; Yoshino A; Murakami N; Sakuta R; Murai T; Nagai T
    Eur J Pediatr; 2004 Aug; 163(8):472-4. PubMed ID: 15160292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine agonists for reducing depression associated with hyperprolactinemia.
    Mattox JH; Buckman MT; Bernstein J; Pathak D; Kellner R
    J Reprod Med; 1986 Aug; 31(8):694-8. PubMed ID: 3772890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bromocriptine treatment of acromegaly.
    Cassar J; Mashiter K; Joplin GF
    Metabolism; 1977 May; 26(5):539-46. PubMed ID: 576725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Terguride as a new anti-hyperprolactinemic agent: characterization in rats and dogs in comparison with bromocriptine.
    Mizokawa T; Akai T; Nakada Y; Yamaguchi M; Nakagawa H; Hasan S; Rettig KJ; Wachtel H
    Jpn J Pharmacol; 1993 Nov; 63(3):269-78. PubMed ID: 7906316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.